FDA Greenlights First Engineered Cell Therapy for a Solid Tumor

Published Date: 05 Aug 2024

Afamitresgene autoleucel (Tecelra) approved for metastatic synovial sarcoma

Read Full News

Latest News

A Century of Schizophrenia: One Disorder or Many?

Researchers increasingly suggest that biological diversity within schizophrenia may limit efforts to identify a single defining biomarker.

Psychotropics Linked to Increased BMI, CVD Risk

Psychotropics are associated with increased BMI, and users with a high BMI genetic risk score and an unhealthy lifestyle have triple the risk for CVD, new research shows.

Adjuvant Radiation Boosts High-Risk Bladder Cancer Control

For patients with high-risk muscle-invasive bladder cancer, adjuvant radiotherapy improves disease control without increasing the risk of serious side effects.

Blood Test Flags Mantle Cell Lymphoma Relapse Before PET-CT

Results pinpoint who has the worst prognosis and might benefit from different therapies.

Nonpharmacologics May Reduce Anxiety, Depression in SUD

Neuromodulation, mind-body therapy, and other nonpharmacologic interventions are linked to improved psychiatric symptoms in people with SUD, a meta-analysis shows.

WHO Warns Loosely Regulated Nicotine Pouches Risk Youth Addiction

The World Health Organization on Friday urged governments to do more to control the sale of nicotine pouches, warning ⁠that the highly addictive products were being...

Todays Updates

Belzutifan Plus Pembro Approved for Adjuvant RCC

LITESPARK-022 trial reports a 28% decrease in risk for disease recurrence or death.

Todays Updates

Belzutifan Plus Pembro Approved for Adjuvant RCC

LITESPARK-022 trial reports a 28% decrease in risk for disease recurrence or death.

Latest News

Researchers increasingly suggest that biological diversity within schizophrenia may limit efforts to identify a single defining biomarker.

Psychotropics are associated with increased BMI, and users with a high BMI genetic risk score and an unhealthy lifestyle have triple the risk for CVD, new research shows.

For patients with high-risk muscle-invasive bladder cancer, adjuvant radiotherapy improves disease control without increasing the risk of serious side effects.

Results pinpoint who has the worst prognosis and might benefit from different therapies.

Neuromodulation, mind-body therapy, and other nonpharmacologic interventions are linked to improved psychiatric symptoms in people with SUD, a meta-analysis shows.

The World Health Organization on Friday urged governments to do more to control the sale of nicotine pouches, warning ⁠that the highly addictive products were being...

News All Time

Next-Generation KRAS G12C Inhibitor Shows 'Robust' Efficacy in Advanced Lung Cancer

Responses observed in patients with and without previous exposure to other KRAS G12C inhibitors

CAR-T Trial Raises Prospect of Preventing Myeloma in High-Risk Group

All 20 smoldering myeloma patients had deep responses after one-time infusion

More Positive Survival Data in Lung Cancer With Perioperative Therapy

High rate of tumor DNA clearance with chemoimmunotherapy portends improved EFS, possibly OS

Study Linking Fruits, Veggies to Lung Cancer Raises Eyebrows

Association by way of pesticide exposure proposed, but outside experts not so sure

SCOTUS Grapples With Multibillion-Dollar Lawsuits Over Roundup Cancer Claims

Several justices seemed sympathetic to Monsanto's argument that it can't be sued under state law

Rectal Cancer 'Crisis'; Smells Like Cancer; Flushing Away Clues to Colon Cancer

News, features, and commentary about cancer-related issues

Lung Cancer Screening Rates in Eligible Adults Remain Low, Uneven

However, rates were improved from previous survey results

FDA Says First 'Real-Time' Clinical Trial Is Underway

Two sponsors are on board, with a larger pilot program planned later this year

Novel Mimetic Bispecific Antibody Superior to Standard Care in Hemophilia A

Mim8 prophylaxis significantly reduced bleeding events in patients with or without inhibitors

High Rate of Surgical Success in Complex NSCLC With Neoadjuvant Chemoimmunotherapy

Three-fourths of patients had cancer-free mediastinal lymph nodes, clear surgical margins in 93%

Pooled Cord Blood Transplants Achieve Near-Perfect Results in Early Trial

Disease-free survival of 96% with no severe GVHD in acute leukemia, other blood cancers

FDA Panel Endorses Capivasertib Use in Prostate Cancer

Agency staff expressed uncertainty over whether PFS benefit was "clinically meaningful"

Paging Dr. AI; Myth Busting in Cancer; Oncologists Shine in Malpractice Survey

News, features, and commentary about cancer-related issues

J. Craig Venter, Who Won the Race to Sequence the Human Genome, Dies at 79

His death followed a hospitalization for cancer treatment side effects

I Was Told I Had 6 Months to Live. That Was 20 Years Ago.

Here's what two brain surgeries taught me about public health and care access

Woman Loses 6-Year Battle With Mouth Tumor

Rare ameloblastoma rapidly recurs and metastasizes despite numerous radical excisions

A person's susceptibility to papillary thyroid cancer may be determined by variations in telomere lengthening genes.

Anticoagulation for 12 months has been found to improve outcomes in cancer patients with minor blood clots.

Participate and win cash vouchers

Get updates on the latest events happening around the world

2.

Do I have prostate cancer? Why a simple PSA blood test alone won't give you the answer

3.

Improved end-of-life conversations for cancer patients are identified by a new study.

4.

Future of Lab-Developed Tests Still Taking Shape

5.

Prostate cancer, rectal exams, Casgevy approved for thalassemia, and two million cancer cases.

1.

Decoding the Failures in Acute Myeloid Leukemia Treatment: Mechanisms, Pathways, & Survival Outcomes

2.

Chloride Test in HCC: Diagnostic Utility, Prognostic Role, and Emerging Insights

3.

Personalized Cancer Vaccines and Neoantigen mRNA: A New Era in Oncology

4.

Unlocking the Mysteries of Rhabdomyoma: A New Hope for Treatment

5.

Understanding Blood Dyscrasia: Symptoms, Causes and Treatment Options

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

2.

Updates on the First Line Management of ALK+ NSCLC

3.

Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option

4.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII

5.

Efficient Management of First line ALK-rearranged NSCLC - Part VII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug Database Drug Interaction Diseases Database

KOL Videos Knowledge Hub Quizzes

Medical Updates Events About Us

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation

FDA Greenlights First Engineered Cell Therapy for a Solid Tumor

Latest News

A Century of Schizophrenia: One Disorder or Many?

Psychotropics Linked to Increased BMI, CVD Risk

Adjuvant Radiation Boosts High-Risk Bladder Cancer Control

Blood Test Flags Mantle Cell Lymphoma Relapse Before PET-CT

Nonpharmacologics May Reduce Anxiety, Depression in SUD

WHO Warns Loosely Regulated Nicotine Pouches Risk Youth Addiction

Todays Updates

Belzutifan Plus Pembro Approved for Adjuvant RCC

Todays Updates

Belzutifan Plus Pembro Approved for Adjuvant RCC

Latest News

News All Time

Next-Generation KRAS G12C Inhibitor Shows 'Robust' Efficacy in Advanced Lung Cancer

CAR-T Trial Raises Prospect of Preventing Myeloma in High-Risk Group

More Positive Survival Data in Lung Cancer With Perioperative Therapy

Study Linking Fruits, Veggies to Lung Cancer Raises Eyebrows

SCOTUS Grapples With Multibillion-Dollar Lawsuits Over Roundup Cancer Claims

Rectal Cancer 'Crisis'; Smells Like Cancer; Flushing Away Clues to Colon Cancer

Lung Cancer Screening Rates in Eligible Adults Remain Low, Uneven

FDA Says First 'Real-Time' Clinical Trial Is Underway

Novel Mimetic Bispecific Antibody Superior to Standard Care in Hemophilia A

High Rate of Surgical Success in Complex NSCLC With Neoadjuvant Chemoimmunotherapy

Pooled Cord Blood Transplants Achieve Near-Perfect Results in Early Trial

FDA Panel Endorses Capivasertib Use in Prostate Cancer

Paging Dr. AI; Myth Busting in Cancer; Oncologists Shine in Malpractice Survey

J. Craig Venter, Who Won the Race to Sequence the Human Genome, Dies at 79

I Was Told I Had 6 Months to Live. That Was 20 Years Ago.

Woman Loses 6-Year Battle With Mouth Tumor

Recommended News For You

In cases of metastatic or recurrent head and neck cancer, gene-guided immunotherapy falls short.

Unlocking the potential of targeted therapies for multiple myeloma